Omkar Speciality Chemicals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Awaiting price reaction for this filing.
Omkar Speciality Chemicals Limited has submitted unaudited financial results for Q3 and 9 months ended December 31, 2025. The auditor R.R. Tibrewala & Co. issued a Qualified Conclusion due to three key issues: (1) The company was under Corporate Insolvency Resolution Process (CIRP), (2) The company failed to prepare financial results for the first three quarters of FY 2024-25, making comparative figures unavailable, and (3) The company has reported losses and has negative net worth, raising material uncertainty about its ability to continue as a going concern. However, the financial results have been prepared on a going concern basis because a Resolution Plan was approved by NCLT on July 31, 2025, after the reporting period. The auditor drew an Emphasis of Matter to this resolution plan approval.
This is a highly distressed filing with negative net worth, ongoing losses, and an auditor qualification. While the NCLT-approved resolution plan offers hope for revival, shareholders face significant uncertainty. The lack of comparative figures and ongoing CIRP status suggest operational challenges. The stock could remain volatile until the resolution plan is fully implemented.